CN106367388A - Method for protecting umbilical cord mesenchymal stem cell culture supernatant at 4 DEG C - Google Patents
Method for protecting umbilical cord mesenchymal stem cell culture supernatant at 4 DEG C Download PDFInfo
- Publication number
- CN106367388A CN106367388A CN201611023963.9A CN201611023963A CN106367388A CN 106367388 A CN106367388 A CN 106367388A CN 201611023963 A CN201611023963 A CN 201611023963A CN 106367388 A CN106367388 A CN 106367388A
- Authority
- CN
- China
- Prior art keywords
- umbilical cord
- stem cell
- culture supernatant
- supernatant
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0668—Mesenchymal stem cells from other natural sources
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Dentistry (AREA)
- Microbiology (AREA)
- Environmental Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Physiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention relates to a method for protecting umbilical cord mesenchymal stem cell culture supernatant at 4 DEG C. The method includes the steps that firstly, a full-term umbilical cord is taken, wherein the full-term umbilical cord needs to be authenticated before being used; then, culture and starvation culture are carried out, supernatant is prepared, and a protective agent is added; finally, cold storage is carried out. By means of the method for protecting the umbilical cord mesenchymal stem cell culture supernatant at 4 DEG C, it can be ensured that the protein content of the stem cell supernatant does not change after the umbilical cord mesenchymal stem cell culture supernatant is stored for 15 days at 4 DEG C, the storage time of the stem cell culture supernatant at 4 DEG C is prolonged, and the transport cost of the stem cell culture supernatant can be greatly reduced.
Description
Technical field
The invention belongs to biological technical field, it is related to a kind of 4 DEG C of guard methods of umbilical cord mesenchymal stem cells culture supernatant.
Background technology
Mescenchymal stem cell (mscs) is found in nineteen sixty-eight, the first passage in bone marrow such as friedenstein aj earliest
Adherent method obtains a kind of fibroblast, further study show that, mscs be initiated by mesoderm have Multidirectional Differentiation and
The adult stem cell of self-renewal capacity, current mscs's is tissue-derived a lot, including bone marrow, fatty tissue, skin histology, umbilicuss
Band blood and umbilical cord tissue etc..
Umbilical cord mesenchymal stem cells derive from neonate and discard umbilical cord tissue, have powerful self-renewal capacity and to fat
Fat cell, neurocyte, hepatocyte and myocyte's differentiation potential, because of its abundance it is easy to obtain, and obtain hurtless measure in addition
Immunogenicity is low, and multiplication capacity is strong, and no matter the advantage such as rationality dispute, is widely used in various clinical researches.
The umbilical cord mesenchymal stem cells secretory component of report is broadly divided into 3 classes: 1, extracellular matrix class at present, such as various
Collagen protein and elastin laminin etc., can promote reinventing of extracellular matrix;2nd, somatomedin class, such as tgf, hgf, vegf and bfgf
Deng;3rd, inflammatory factor and chemotactic factor class, such as pge2, il-6, il-8 etc..Due to umbilical cord mesenchymal stem cells can secrete multiple
The factor, therefore, increasing research concentrates on the paracrine action of stem cell, and research shows, stem cell paracrine action pair
Skin injury is repaired, and participates in the aspects such as the immune response of body and has important effect.
Multiple factors of umbilical cord mesenchymal stem cells secretion mostly are protein ingredient, how to guarantee in stem cell supernatant effectively because
The content of son, is current urgent problem, is also to directly affect one of bottleneck of stem cell clinical practice, extends egg at present
The only effective method of white holding time is to reduce to preserve temperature DEG C, and conventional is that less than -20 DEG C temperature DEG C preserve, and this also gives albumen
The transport of class material increased cost, the present invention based on extend umbilical cord mesenchymal stem cells culture supernatant resting period, really
Protect the content of stem cell secretion factor, providing for Clinical practice stem cell secretion factor may.
Content of the invention
It is an object of the invention in place of overcoming the deficiencies in the prior art, providing in a kind of umbilical cord mesenchymal stem cells culture
Clear 4 DEG C of guard methods, this method extends 4 DEG C of resting periods of umbilical cord mesenchymal stem cells culture supernatant.
The technical solution used in the present invention is:
A kind of 4 DEG C of guard methods of umbilical cord mesenchymal stem cells culture supernatant, step is as follows:
(1) take fully a moon healthy fetus umbilical cord, detect cord serum with the method that gold colloidal, fluorescent quantitation pcr combine
Hbsag, anti-hcv, hcv-rna, anti-hdv, anti-hev, anti-hiv-1/2, hiv-1-rna, cmv-dna, testing result is the moon
The umbilical cord of property can use;
(2) umbilical cord is placed in sterilized petri dishes, is cut into the segment of 5cm with aseptic operation, is repeatedly cleaned with pbs and remain in
Endovascular blood, till the pbs after cleaning is substantially colorless;
(3) the umbilical cord after cleaning is transferred in kidney basin, after peeling off umbilical vein and umbilical artery, with operating scissorss, umbilical cord is irrigated and time
Glue cuts into the fritter of 1-5mm, evenly laid out to t75 culture bottle bottom;
(4) the culture bottle of the umbilical cord tissue block that tiled is put in CO2 gas incubator, be dried 30 minutes;
(5) it is slowly added to the culture medium containing 10% hyclone and serum albumin additive toward in culture bottle, culture medium
Consumption is advisable with just submergence piece of tissue;
(6) change within every 6 days liquid 1 time, tissues observed paste block border cell's growing state, treat most of piece of tissue cells climb out of and
Cell growth around each block organization's block, to during 80% about fusion, carries out the primary of umbilical cord mesenchymal stem cells and passes on;
(7) press 8000cells/cm2Density inoculation p4 for umbilical cord mesenchymal stem cells cell in t75 culture bottle, add
10ml df12 complete medium;
(8) when cell length to 80% merges, with 5mlpbs wash buffer cell surface 3 times;
(9) exhaust pbs buffer, add the hungry culture of 10mldf12 culture medium 72 hours;
(10) collect the umbilical cord mesenchymal stem cells culture supernatant after hungry culture 72 hours, supernatant is collected 50ml centrifugation
300g in pipe, room temperature is centrifuged 5 minutes;
(11) abandon precipitation, collect stem cell culture supernatant, with the bag filter of 5kd, stem cell supernatant is concentrated, concentrate
10 times, obtain the effective stem cell secretion hybrid cytokine containing more than 5kd molecular weight;
(12) in stem cell culture supernatant after concentration, add the Mannitol of 10 volume ratio % glycerol or 10%g/ml, as
Stem cell culture supernatant protective agent, puts into 4 DEG C of Refrigerator stores using without protectant stem cell culture supernatant as comparison.
And, described step (12) in stem cell culture supernatant in add 5% volume ratio glycerol, after incubation 30 minutes, then
Add the Mannitol of 5%g/ml.
The invention has the benefit that
4 DEG C of guard methods of umbilical cord mesenchymal stem cells culture supernatant that the present invention provides add interpolation protection in cold-storage
4 DEG C of times deposited of stem cell supernatant can be extended, providing for clinical practice stem cell secretion factor may after agent.
4 DEG C of guard methods of umbilical cord mesenchymal stem cells culture supernatant that the present invention provides guarantee 4 DEG C deposit 15 days after, do thin
Protein content in born of the same parents' supernatant does not change, and extends the resting period of 4 DEG C of stem cell culture supernatant, can substantially reduce stem cell training
The cost of transportation of foster supernatant.
The protective agent adding, glycerol or Mannitol do not affect the molecular structure of supernatant composition and composition, and as skin
During beauty treatment, certain effect can also be strengthened to a certain extent.
Specific embodiment
With reference to specific embodiment, the invention will be further described, and following examples are descriptive, is not limit
Qualitatively it is impossible to protection scope of the present invention is limited with this.
A kind of 4 DEG C of guard methods of umbilical cord mesenchymal stem cells culture supernatant, step is as follows:
(1) take fully a moon healthy fetus umbilical cord, detect cord serum with the method that gold colloidal, fluorescent quantitation pcr combine
Hbsag, anti-hcv, hcv-rna, anti-hdv, anti-hev, anti-hiv-1/2, hiv-1-rna, cmv-dna, testing result is the moon
The umbilical cord of property can use;
(2) umbilical cord is placed in sterilized petri dishes, with aseptic operation be cut into 5cm about segment, repeatedly cleaned residual with pbs
Stay endovascular blood, till the pbs after cleaning is substantially colorless;
(3) the umbilical cord after cleaning is transferred in kidney basin, after peeling off umbilical vein and umbilical artery, with operating scissorss, umbilical cord is irrigated and time
Glue cuts into the fritter of 1-5mm, evenly laid out to t75 culture bottle bottom;
(4) the culture bottle of the umbilical cord tissue block that tiled is put in CO2 gas incubator, be dried 30 minutes;
(5) it is slowly added to the culture medium containing 10% hyclone and serum albumin additive toward in culture bottle, culture medium
Consumption is advisable with just submergence piece of tissue;
(6) change within every 6 days liquid 1 time, tissues observed paste block border cell's growing state, treat most of piece of tissue cells climb out of and
Cell growth around each block organization's block, to during 80% about fusion, carries out the primary of umbilical cord mesenchymal stem cells and passes on;
(7) press 8000cells/cm2Density inoculation p4 for umbilical cord mesenchymal stem cells cell in t75 culture bottle, add
10ml df12 complete medium;
(8) when cell length to 80% about merges, with 5mlpbs wash buffer cell surface 3 times;
(9) exhaust pbs buffer, add the hungry culture of 10mldf12 culture medium 72 hours;
(10) collect the umbilical cord mesenchymal stem cells culture supernatant after hungry culture 72 hours, supernatant is collected 50ml centrifugation
300g in pipe, room temperature is centrifuged 5 minutes;
(11) abandon precipitation, collect stem cell culture supernatant, with the bag filter of 5kd, stem cell supernatant is concentrated, concentrate
10 times, obtain the effective stem cell secretion hybrid cytokine containing more than 5kd molecular weight;
(12) in stem cell culture supernatant after concentration, add the Mannitol of 10 volume ratio % glycerol or 10%g/ml, as
Stem cell culture supernatant protective agent, puts into 4 DEG C of Refrigerator stores using without protectant stem cell culture supernatant as comparison;
(14) the concentration of albumen in each group stem cell supernatant after depositing 15 days, is measured with cck-8.
The present invention step (12) in stem cell culture supernatant in add 5% volume ratio glycerol, after incubation 30 minutes, then
Add the Mannitol of 5%g/ml, as stem cell culture supernatant protective agent, to make without protectant stem cell culture supernatant
For comparison, place into 4 DEG C of Refrigerator stores.
Table 1: the protein content in stem cell culture supernatant
Claims (2)
1. a kind of 4 DEG C of guard methods of umbilical cord mesenchymal stem cells culture supernatant it is characterised in that: step is as follows:
(1) take fully a moon healthy fetus umbilical cord, detect cord serum hbsag with the method that gold colloidal, fluorescent quantitation pcr combine,
Anti- hcv, hcv-rna, anti-hdv, anti-hev, anti-hiv-1/2, hiv-1-rna, cmv-dna, testing result is the umbilicuss of feminine gender
Band can use;
(2) umbilical cord is placed in sterilized petri dishes, is cut into the segment of 5cm with aseptic operation, is repeatedly cleaned with pbs and remain in blood vessel
Interior blood, till the pbs after cleaning is substantially colorless;
(3) the umbilical cord after cleaning is transferred in kidney basin, after peeling off umbilical vein and umbilical artery, with operating scissorss, umbilical cord jelly of Wharton is cut
Be cut into the fritter of 1-5mm, evenly laid out to t75 culture bottle bottom;
(4) the culture bottle of the umbilical cord tissue block that tiled is put in CO2 gas incubator, be dried 30 minutes;
(5) it is slowly added to the culture medium containing 10% hyclone and serum albumin additive, the consumption of culture medium toward in culture bottle
It is advisable with just submergence piece of tissue;
(6) change within every 6 days liquid 1 time, tissues observed paste block border cell's growing state, treat that most of piece of tissue cells climb out of and each
Cell growth around block organization's block, to during 80% about fusion, carries out the primary of umbilical cord mesenchymal stem cells and passes on;
(7) press 8000cells/cm2Density inoculation p4 for umbilical cord mesenchymal stem cells cell in t75 culture bottle, add 10ml
Df12 complete medium;
(8) when cell length to 80% merges, with 5ml pbs wash buffer cell surface 3 times;
(9) exhaust pbs buffer, add the hungry culture of 10ml df12 culture medium 72 hours;
(10) collect the umbilical cord mesenchymal stem cells culture supernatant after hungry culture 72 hours, supernatant is collected in 50ml centrifuge tube
300g, room temperature is centrifuged 5 minutes;
(11) abandon precipitation, collect stem cell culture supernatant, with the bag filter of 5kd, stem cell supernatant is concentrated, concentrate 10 times,
Obtain the effective stem cell secretion hybrid cytokine containing more than 5kd molecular weight;
(12) add the Mannitol of 10 volume ratio % glycerol or 10%g/ml in stem cell culture supernatant after concentration, as dry thin
Born of the same parents' culture supernatant protective agent, puts into 4 DEG C of Refrigerator stores using without protectant stem cell culture supernatant as comparison.
2. 4 DEG C of guard methods of umbilical cord mesenchymal stem cells culture supernatant according to claim 1 it is characterised in that: described
Step (12) in stem cell culture supernatant in add 5% volume ratio glycerol, after incubation 30 minutes, add the manna of 5%g/ml
Alcohol.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611023963.9A CN106367388B (en) | 2016-11-14 | 2016-11-14 | Umbilical cord mesenchymal stem cell culture supernatant 4 ℃ protection method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611023963.9A CN106367388B (en) | 2016-11-14 | 2016-11-14 | Umbilical cord mesenchymal stem cell culture supernatant 4 ℃ protection method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106367388A true CN106367388A (en) | 2017-02-01 |
CN106367388B CN106367388B (en) | 2021-01-01 |
Family
ID=57891037
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611023963.9A Active CN106367388B (en) | 2016-11-14 | 2016-11-14 | Umbilical cord mesenchymal stem cell culture supernatant 4 ℃ protection method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106367388B (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106880645A (en) * | 2017-02-28 | 2017-06-23 | 天津普瑞赛尔生物科技有限公司 | Enema liquid containing mescenchymal stem cell secretion for small household pet and preparation method thereof |
CN108103014A (en) * | 2017-12-28 | 2018-06-01 | 重庆斯德姆生物技术有限公司 | A kind of method for preserving of umbilical cord mesenchymal stem cells culture supernatant |
CN108496957A (en) * | 2018-06-04 | 2018-09-07 | 北京中广天生物科技有限公司 | The deepfreeze store method of umbilical cord mesenchymal stem cells culture supernatant |
CN108517002A (en) * | 2018-04-20 | 2018-09-11 | 命之本源医疗科技(北京)有限公司 | A kind of stabilizer of stem cell culture supernatant secretory protein |
CN108753706A (en) * | 2018-06-04 | 2018-11-06 | 北京中广天生物科技有限公司 | Application of the white flower loropetalum chinense in preparing umbilical cord mesenchymal stem cells culture supernatant |
CN112640890A (en) * | 2020-12-30 | 2021-04-13 | 重庆市铂而斐细胞生物技术有限公司 | Cell preserving fluid for delaying cell growth in cell culture and preparation method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105434468A (en) * | 2015-12-15 | 2016-03-30 | 天津市康婷生物工程有限公司 | Preparation method of skin cell damage repairing reagent |
CN105505865A (en) * | 2015-12-15 | 2016-04-20 | 天津市康婷生物工程有限公司 | Separation method for umbilical cord mesenchymal stem cells |
-
2016
- 2016-11-14 CN CN201611023963.9A patent/CN106367388B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105434468A (en) * | 2015-12-15 | 2016-03-30 | 天津市康婷生物工程有限公司 | Preparation method of skin cell damage repairing reagent |
CN105505865A (en) * | 2015-12-15 | 2016-04-20 | 天津市康婷生物工程有限公司 | Separation method for umbilical cord mesenchymal stem cells |
Non-Patent Citations (5)
Title |
---|
LAI RC ET.AL: "Derivation and characterization of human fetal MSCs: an alternative cell source for large-scale production of cardioprotective microparticles.", 《J MOL CELL CARDIOL》 * |
孟胜男编: "《药剂学》", 30 September 2011, 上海:上海科学技术出版社 * |
时炳正等: "4℃条件下保存不同时间点小鼠骨髓间充质干细胞的细胞活性和生物学特性研究", 《口腔医学研究》 * |
赵克健主编.: "《新药与临床评价》", 30 June 2003, 天津:天津科学技 * |
陈津等: "大规模间充质干细胞培养技术评估报告", 《中国医药生物技术》 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106880645A (en) * | 2017-02-28 | 2017-06-23 | 天津普瑞赛尔生物科技有限公司 | Enema liquid containing mescenchymal stem cell secretion for small household pet and preparation method thereof |
CN108103014A (en) * | 2017-12-28 | 2018-06-01 | 重庆斯德姆生物技术有限公司 | A kind of method for preserving of umbilical cord mesenchymal stem cells culture supernatant |
CN108517002A (en) * | 2018-04-20 | 2018-09-11 | 命之本源医疗科技(北京)有限公司 | A kind of stabilizer of stem cell culture supernatant secretory protein |
CN108496957A (en) * | 2018-06-04 | 2018-09-07 | 北京中广天生物科技有限公司 | The deepfreeze store method of umbilical cord mesenchymal stem cells culture supernatant |
CN108753706A (en) * | 2018-06-04 | 2018-11-06 | 北京中广天生物科技有限公司 | Application of the white flower loropetalum chinense in preparing umbilical cord mesenchymal stem cells culture supernatant |
CN112640890A (en) * | 2020-12-30 | 2021-04-13 | 重庆市铂而斐细胞生物技术有限公司 | Cell preserving fluid for delaying cell growth in cell culture and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN106367388B (en) | 2021-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106367388A (en) | Method for protecting umbilical cord mesenchymal stem cell culture supernatant at 4 DEG C | |
Moon et al. | Human adipose tissue-derived mesenchymal stem cells improve postnatal neovascularization in a mouse model of hindlimb ischemia | |
CN106344493A (en) | Preparation method of essence containing human mesenchymal stem cell factors | |
CN104560869B (en) | A kind of method for preparing chorion mescenchymal stem cell | |
Li et al. | Adipose tissue stromal cells transplantation in rats of acute myocardial infarction | |
JP6555691B2 (en) | Activator of mesenchymal stem cells, activated mesenchymal stem cells and method for producing the same | |
CN103074298B (en) | A kind of Human fat mesenchymal stem cell bank and construction process thereof | |
EP2511365A2 (en) | Method for inducing migration of adult stem cells derived from adipose tissue | |
CN105713871A (en) | Human chorion mesenchymal stem cell isolated culture method | |
KR20190055790A (en) | Isolation of mesenchymal stem cells from umbilical cord amniotic membrane using cell culture medium | |
CN110693909A (en) | Preparation of umbilical cord mesenchymal stem cell factor with hair growth effect | |
CN104225667B (en) | Angiogenesis-facilitating temperature-sensitive hydrogel powder and temperature-sensitive hydrogel prepared from same | |
TW200902718A (en) | Procurement, isolation, and cryopreservation of endometrial/menstrual cells | |
CN104480533A (en) | Placenta stem cell bank construction method and placenta tissue resuscitation method | |
CN103272258A (en) | Novel freeze-drying platelet-rich fibrin, as well as preparation and application thereof | |
CN104523753A (en) | Preparation method, product and application of human umbilical cord mesenchymal stem cell cultural supernatant active factor and cell lysis buffer | |
CN106038598A (en) | Method for preparing human-derived stem cell secretion bioactive factor and lysate | |
WO2018010588A1 (en) | Therapeutic agent for restoring body function aging and delaying organ function decline | |
CN108753708A (en) | A kind of preparation method of Stem Cell Activity factor freeze-dried powder | |
CN105368780A (en) | Lavage fluid, enzymatic hydrolysate and method for separating placenta hematopoietic stem cells | |
CN107189982A (en) | A kind of cultural method of human umbilical cord mesenchymal stem cells | |
CN104983742A (en) | Stem cell preparation for treating degenerative osteoarthropathy and preparation method of stem cell preparation | |
CN109453200A (en) | The preparation method of mostly tissue-derived mescenchymal stem cell factor lytic freeze-dried powder | |
JP2024069365A (en) | Methods for inducing or improving wound healing properties of mesenchymal stem cells - Patents.com | |
CN112056307A (en) | Umbilical cord preservation liquid and umbilical cord preservation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: No. 9 Saida South Road, Xiqing Economic and Technological Development Zone, Tianjin 300200 Applicant after: TIANJIN KANGTING BIOLOGICAL ENGINEERING GROUP Co.,Ltd. Address before: 300200 Tianjin Saida Industrial Park Xiqing District Xiqing pharmaceutical economic and Technological Development Zone Friendship Road No. 126 Applicant before: TIANJIN KANGTING BIOTECHNOLOGY Co.,Ltd. |
|
CB02 | Change of applicant information | ||
GR01 | Patent grant | ||
GR01 | Patent grant |